Dr. Mutiu A. JIMOH

Profile

	Name: Mutiu A. JIMOH
	Designation: Senior Lecturer
	Faculty: CLINICAL SCIENCES
	Department: Radiation Oncology
	Phone Number: +234 8035628662
	Google Scholar Profile Research Gate Profile ORCID Profile
	Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Alternate Email Address 1: This email address is being protected from spambots. You need JavaScript enabled to view it. Alternate Email Address 2: This email address is being protected from spambots. You need JavaScript enabled to view it.
Biography: DR JIMOH MUTIU ALANI graduated from Olabisi Onabanjo University in Ogun State, where he received his first degree in Bachelor of Medicine, Bachelor of Surgery (M.B.CH. B) 2005. He joined the University College Hospital Ibadan in 2008 for his Post-graduate training. There, he completed his residency fellowship training in Radiation/Clinical Oncology. He is a Member of the America Society for Clinical Oncology, is Board certified in Clinical/Radiation Oncology by the West Africa College of Surgeons. He has special interests in the treatment of Head & Neck, Breast, Gastrointestinal & Gynaecological oncology sub-specialties.He proceeded to University of Ibadan   to obtained  master of Science (M.Sc.) Chemical Pathology, 2018 and various professional certificates, including certificates in Leadership and management in health, project management in health and implementation science in health all at University of Washington, United State. He is a member of the National Postgraduate Medical College.  Board member faculty of Radiology by the West Africa College of Surgeons, Association of Radiologists of West African and African Organization of Research and Training. Dr. Jimoh has a zeal for research and is widely published in various international and local journals. He has special interests in the treatment of Gynaecological, Head & Neck, Breast and Gastrointestinal cancers. From 2019  -till date Dr jimoh was pioneer principal investigator of the Gene Expression Profiling of Non-Communicable Diseases in Nigeria.  (54 Gene Heritage Study Grant. 2019). He currently practices as a Consultant Clinical/Radiation Oncologist/ senior Lecturer at University College Hospital, Ibadan and University of Ibadan. Area of Specialization Majority (75%) of Dr jimoh ‘s publication are in the field of breast cancer, gynaecological, Head&neck, Gastrointestinal and pediatric cancer. The early part of his research work was conducted at the different  facet of healthcare, cancer patient in Nigeria. The first large scale study of the prevalence and pattern of cancer attending a Nigerian healthcare center  setting was researched.

Resume

Click here for my resume

Research

Gene Expression Profiling of Non-Communicable

Diseases in Nigeria. (P.I). 54 Gene Heritage Study Grant - 2019.

Publications

Articles that have already appeared in learned journals:

1. Adenipekun, A.A., Jimoh M.A. Chemoradiation of Squamous Cell Carcinoma of Left Conjunctive in a HIV Positive Man. American Journal of Research Communication 2013: Vol 1(8) pp108-113.  (USA) (Contribution: 50%)

2 .Adenipekun A.A., Jimoh, M.A., Elumelu, T.N. Second Malignancy in a Patient with Long Survival from Solitary Plasmacytoma Previously Treated with Radiation. A Case Report, Cancer Biology 2015: Vol5(4)PP22-25.  (USA)            (Contribution: 50%)

3. Adekanbi, A.O.A., Jimoh, M.A., Ajani, M.A., Fawole, A.O. Endometrial Cancer in Ibadan: Epidemiological and Clinico-pathological Features. New York Science Journal 2016:Vol 9(3)PP19-23. (USA)        (Contribution: 20%)

4. Salako O., Habeeb M.V., Jimoh, M.A. An Index care of desmoplastic small round blue cell tumour in Nigeria Journal of most African College of Surgery acceptance on 24-4-16.          (Nigeria) (Contribution: 40%)

5. A Oladeji, O Atalabi, M Jimoh, I Ntekim, T Elumelu (2016). Delay in Presentation of Cancer Patients for Diagnosis and Management: An Institutional Report. The Internet Journal of Oncology. Volume 13 Number 1.  (USA) (Contribution: 30%)

6. Abdus-Salam, A.A, Olabumuyi, A., Jimoh, M.A. Recent Advances in the Management of Renal Cell Carcinoma; A Narrative Review. Nigeria Journal of Clinical Practice.  (Nigeria) (Contribution: 40%)

7. C Nwogu, M. Masika, A Saunders ,I. Nwogu, M Jimoh, C Gaudioso. An  International Virtual Multidisciplinary Tumor Board-A Pilot Study. (USA) (Contribution: 20%)

8. Chukwumere E. Nwogu, Martin Mahoney, Ifeoma Okoye, Kenneth Ejiogu, Saby George, Grace Dy, Mutiu Jimoh, Omolola Salako, Oge Ilegbune, Bindiya Chugani, Emmanuel Ezeome, Abiodun O. Popoola, and Arthur M. Michalek (2016). Role of Private Enterprise in Cancer Control in Low to Middle Income Countries, Journal of Cancer Epidemiology, Volume, Article ID 7121527, 5 pages. (USA) (Contribution: 20%)

9. Ismaila .N, Salako .O, Oladeji A.A, Jimoh M.A. Oncology Guidelines  Usage in a low and Middle income countries. Journal of Global Oncology, CLICK HERE. (USA) (Contribution: 30%)

10. Emmanuel O. Oyekunle, Bidemi I. Akinlade and Mutiu A. Jimoh (2018). Study of the relationships between brachytherapy plan parameters in an attempt to verify total dwell time in vaginal cylinder applications. Journal of Applied Clinical Medical Physics. Vol; 19(4): 68–74. (USA) (Contribution: 30%)

11. Araron Saunder, Carmelo Gadioso, Jimoh Mutiu, Ugonna Ajoku, Saby George, Traceyo’ Connor and Chukwumere Nwogu. Research Article, Can International Expertise Be Leveraged for Multidisciplinary Cancer Care in LMIC’s. Radiotherapy and Clinical Oncology. (USA) (Contribution: 30%)

12. Onifade A.A, Ajadi T.A, Jimoh I.O, Jimoh M.A, Oluogun W.A. Paraparesis in HIV Infected Patient without Constitutional Clinical features. Annal for Postgraduate Medical Journal (ARD) UCH. (Nigeria) (Contribution: 50%) 

13. J.K. Molade1 , A.A. Onifade1 , M.A. Jimoh2 , O.G. Oyero3 , I.C. Ahube1 , O.K. Olawuyi1 and I. Ayodeji. Estimation Of Immunological And Biochemical Parameters In Hepatitis B Positive Patients . Ann Ibd. Pg. Med 2020. Vol.18, No.1 31-36 (Contibution : 30%)

14.  Akinyemiju I, Jimoh M.A, Salakwo O. Palliative Care Awareness among Health Care Professional in Lagos, Nigeria.Journal of Clinical Oncology. (USA) (Contribution: 60%)

15.  Salako Omolola1, Aliyu Usman Malami2, *, Jimoh Mutiu Alani3, Oboh Oseiwe Evaristus4,  Nwankwo Kenneth5, Ogunnorin Babatunde Olutoye2, Habeeb Muhammed1,  Olukiran Olugbenro Emmanueal1, Ahmed Rilwan8, Joseph Adedayo1, Roberts Alero Ann6, Oyesegun Razaak8, Ketiku Kingsley Kayode7, Adenipekun Adeniyi Adesina2,  Campbell Oladapo Babatunde2, Adewuyi Sunday9, Chukwuocha Ikechukwu9,  Otene Samuel Anaja9, Duncan Josbert Thomas Kofi7, Durosinmi-Etti Francis Abayomi1 (2018).Techniques and Practice of Post Mastectomy Radiotherapy in Nigeria: A Multi-Centre Study . International Journal of Clinical Oncology and Cancer Research; 3(3): 41-48 CLICK HERE doi 10.11648/j.ijcocr.20180303.15 ISSN: 2578-9503 (Print); ISSN: 2578-9511 (Online). (USA) (Contribution: 20%)

16.  Oreoluwa Arowojolu, Oluwasegun Afolaranmi, Mutiu Jimoh. Aggressive mycosis fungoides/sѐzary syndrome in Nigeria: case report and literature review. International Journal of Research in Dermatology. (USA) (Contribution: 30%)

17.         Chinosom Ugochukwu Nwozichi, Theresa A. Guino, Amarachi Marie Madu, Raul Hormazabal-Salgado, Mutiu Alani Jimoh, Oluwatosin Taiwo Arungwa (2020). The Troubled Nurse: A Qualitative Study of Psychoemotional Effect of Cancer Care on Nurses in a Nigeria Cancer Setting. Asia-Pacific journal of Oncology Nursing. Vol. 7. Issue 4. (Asia) (Contribution: 30%)

18. Nwozichi, C. U., Musah,K. T., Madu, A. M., Guino-o, T. A., Arungwa, O. T. Jimoh, M. A. (2020). Contextualizing the cultural factors associated with cancer care in Nigeria:  An Ethnonursing Study Journal of Transcultural  Nursing 1–7 (USA) (Contribution: 30%)

19. Abimbola Fapohunda,1 Adeola Fakolade,2 Jesutofunmi Omiye,3 Oluwasegun Afolaranmi,3 Oreolwa Arowojolu,3 Tunde Oyebamiji,3Chukwumere Nwogu,4 Alexander Olawaiye,5 Jimoh Mutiu4 Cancer presentation patterns in Lagos, Nigeria: Experience from a private cancer center. Journal of Public Health in Africa 2020; 11:1138 (Contribution: 20%)

20. Onifade, A.A, Jimoh, M.A. Preliminary Safety Profiles of Herbal Medicine, Nimreh B for Viral Chronic Hepatitis B Infection Among Human. African Journal of Medicine and Medical Sciences. 2020. (Nigeria) (Contribution: 50%).

21. Abdus-Salam A.A, Orekoya A,A, Jimoh M.A, Olabumuyi A.A.Radiotherapy Treatment of Keloids in Ibadan.Journal of West Africa College of Surgeon 2016Oct-Dec6(4);104-106.(Contribution: 30%)

22. Abdus-Salam A, Folorunso S, Akinlade B, Jimoh M and Salako B. Radiation Oncology in Nigeria; rescuing a fast receding, yet crucially important medical specialty (2020) 49, 339-344.(Contribution: 20%)

23. Abbas Abdus-Salam, Adeniyi Adedayo Olabumuyi, Ajibike Ayomide Orekoya, Mutiu A. Jimoh. Radiotherapy treatment of spinal metastases in Ibadan: A 9 year review (2020). (Contribution: 30%)

24. Mutiu A. Jimoh, Mustapha A. Ajani, Sharif A. Folorunso, Ebenezer O. Fatunla, Chinedu S. Aruah, Abbas A. Abdus-Salam, John Olufemi Ogunbiyi. One year of breast cancer in Ibadan, Southwestern Nigeria: a histopathological review (2021).(Contribution: 20%)

25. Abbas abdus salam, Atara Ntekim, Sharif Folorunso,Ayorinde Folasire, Mutiu Jimoh, Adeniyi Adenipekun Pre-treatment knowledge and side -efffects Experienced during Chemotherapy for Breast Cancer in a Nigerian Tertiary Hospital.Nigerian medical journal (2021). Volume(62)

26. Adedayo Joseph, Adeseye Akinsete, Bolanle Adegboyega, Opeyemi Awofeso, Mutiu Jimoh, Muhammad Habeebu.Childhood cancer in Nigeria: The effect of a handbook in the experiences of caregivers.Nigerian Journal of Paediatrics (2022) Volume (49), (1): 8 – 13

27. Adedayo Joseph, MD1 ; Bankole Olatosi, PhD2 ; Mohammad Rifat Haider, PhD3 ; Bolanle C. Adegboyega, MD1; Nwamaka N. Lasebikan, MD4 ; Usman M. Aliyu, MD5 ; Musa Ali-Gombe, MD6 ; Mutiu A. Jimoh, MD7,8; Olusegun Abayomi Biyi-Olutunde, MD9 ; Opeyemi Awofeso, MD10; Omolara Aminat Fatiregun, MD11; Evaristus Oseiwe Oboh, MD12; Emmanuella Nwachukwu, MD13; Ismail H. Zubairu, MD14; Samuel A. Otene, MD15; Oluwatoyin I. Iyare, MD16; Temitope Andero, MD17; Alabi Babatunde Musbau, MD18; Azeezat Ajose, MD10; and Adedayo A. Onitilo, MD, PhD, MSCR.Patient’s Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria. American society of clinical oncology.(2022).

28. Adedayo Olufemi Joseph1 , Onyinye D. Balogun2 , Adeseye M. Akinsete3 , Muhammad Yaqub Habeebu4 , Mutiu Alani Jimoh5 , Nwamaka N. Lasebikan6 , Kanyinsola A. Oyeyinka7 , Korede T. Akindele8 , Opeyemi Mercy Awofeso. Early Detection of Paediatric Cancer: Equipping Primary Health‑Care Workers in Nigeria. Nigerian Journal of medicine. (2022).

29.Abbas A. Abdus-Salam, Adeniyi Adedayo Olabumuyi, Mutiu Alani Jimoh, Sharif Adeniyi Folorunso, Ajibike Ayomide Orekoya. The role of radiation treatment in the management of inflammatory musculoskeletal conditions: a revisit (2020).(Contribution: 20%)

30. Segun Fatumo, Aminu Yakubu, Abdullahi Musa, Abdulrasheed M. Mujtaba, Abiodun Popoola, Abubakar M. Bello, Anthony Anyanwu, Ashiru Yusuf, Gesiye EL Bozimo, Goddy Bassey, Hadiza Bala, Istifanus Bala Bosan, Jemimah Edah, Mutiu Alani Jimoh, Kenneth Nwankwo, Olalekan Ojo, Marcus Inyama, Maryam Apanpa, Mohammed Mustapha, Musa Ali-Gombe, Olubukola Ojo, Oludare Adeyemi, Samuel Ajayi, Sanusi Bala, Temitope Ojo, Usman Malami Aliyu, Yemi Raji, Zainab Tanko, Amina Mohammed, David Oladele, Muhammed Hamzat, Emmanuel Agaba, Emeka Nwankwo, Ifeoma Ulasi, Jonah Musa, Umeora Odidika, Omolola Salako, Oyekanmi Nashiru, Babatunde L Salako, Colm O’Dushlaine & Abasi Ene-Obong.Promoting the genomic revolution in Africa through the Nigerian 100K Genome Project.Nature journal (2022). volume (54).pages (531–536).

Supervision

           CURRENT STUDENTS

1. Successfully supervised 1 MSc and 1 PhD student.

2. Currently supervising one PhD student.

PHD Student

1. PROJECT TITLE: The Troubled Nurse: A Qualitative Study of Psychoemotional Effect of Cancer Care on Nurses in a Nigeria Cancer Setting.. Asia-Pacific journal of Oncology Nursing. Vol. 7. Issue 4. (Asia) (Contribution: 30%)
STUDENT NAME: Chinosom Ugochukwu Nwozichi
EXAMING BODY: Babcock University, Ogun State
YEAR OF ENTRY: 2019

2. PROJECT TITLE: chemotherapy induced electrolyte disorder and Nephrotoxicity in cancer patient from selected Nigeria  tertiary health care.
STUDENT NAME:  John Abiodun Obadipe
EXAMING BODY: University of Ibadan
YEAR OF ENTRY: 2019

 MSC PROJECT

3. PROJECT TITLE : Prevalence of Chemotherapy-induced Neuthropenia and its complication among breast cancer patient in two centers  in south west Nigeria.
STUDENT NAME: Aisha Oluwaseun, Gbadamosi
EXAMING BODY: University of Ibadan
YEAR OF ENTRY: 2019

 

Grants

Gene Expression Profiling of Non-Communicable  2019

Diseases in Nigeria. (P.I). 54 Gene Heritage Study Grant.            
Current Grant Funding

Title :54Gene Heritage study
Funder : Abasi Ene-Obong
Brief Summary: 54gene is a research, services and development company located in Nigeria and the United States. The company was founded in 2019 by Dr Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. 54gene utilises human genetic data from diverse African populations, to improve the development, availability and efficacy of medical products that will prove beneficial to Africans and the wider global population.NCD-GHS Consortium is a partnership of Nigerian geneticists from 54gene, Nigeria Institute of Medical Research (NIMR), the National Biotechnology Development Agency's Centre for Genomics Research and Innovation (NABDA-CGRI), London School of Hygiene and Tropical Medicine (LSHTM). The consortium will study cardio-metabolic diseases, neurodegenerative diseases, cancers that are more prevalent on the African continent, endocrine disorders and sickle cell disease.
Role: Principal investigator
Collaborator: Dr Esan A., Dr Akingbola T. , Dr Adebiyi A.A

Social Media Handle

Facebook: Profile Link	LinkedIn: Profile Link	Twitter: Profile Link
Instagram: Profile Link	YouTube: Profile Link	Pinterest: Profile Link

Other Interest/Hobbies

 Not available